DOJ Drops DaVita Inquiry

DENVER--(BUSINESS WIRE)-- DaVita Inc. (NYSE:

) announced that the United States Attorney's Office (USAO) for St. Louis recently informed the company that the USAO completed its investigation and is not taking any action against the company. In March 2005, the St. Louis USAO initiated its inquiry with a subpoena and subsequent document requests in connection with a joint civil and criminal investigation. The broad requests covered a range of topics including financial relationships with physicians and joint ventures. They also covered other services provided to patients, including the administration and billing of Epogen®. DaVita® fully cooperated with the government investigation, providing hundreds of thousands of documents. The USAO closed its investigation without filing any charges, without